|
Monday 8th April 2024 |
Text too small? |
Heartland announces indicative regulatory approval of Challenger Bank acquisition, and NZ$210m equity raise
Heartland Group Holdings Limited (Heartland) (NZX/ASX: HGH) is pleased to announce that it has received indicative regulatory approvals from the Australian Prudential Regulation Authority (APRA) and the Reserve Bank of New Zealand (RBNZ) for Heartland Bank Limited’s acquisition of Challenger Bank Limited from Challenger Limited (ASX: CGF).
Heartland also announces a NZ$210 million equity raise, comprising an NZ$105 million underwritten institutional placement (Placement) and a NZ$105 million underwritten 1 for 6.85 accelerated non-renounceable entitlement offer (Entitlement Offer).
APRA and RBNZ’s final regulatory approvals are conditional on the successful completion of the Placement and Entitlement Offer.
Included in this announcement is:
1. Offer Announcement
2. Offer Document
3. Investor Presentation
4. NZX Corporate Action Notice
5. Cleansing Notice
ENDS
No comments yet
Rua Bioscience Market Update
FSF - Fonterra announces interim leadership changes
April 29th Morning Report
NZK - Blue Endeavour Pilot Farm and Wellboat Update
TRU - FY 31 March 2026 Revenue and Results Guidance Achieved
FBU - Fletcher Building sale of Fletcher Reinforcing and Wire
April 28th Morning Report
RYM - Ryman Healthcare appoints new independent director
ikeGPS 4Q FY26 and Full Year FY26 Performance Update
HGH - Heartland trading update